Option chain shows key data for Ethernity Networks's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Ethernity Networks.

Ethernity Networks (OTC:ENETF) Stock, Option Chain

Ethernity Networks Ltd technology solutions provider that develops and delivers data processing technology and solutions used in high-end Carrier Ethernet applications across the telecom, mobile, security, and data center markets. The company's only operating segment is the development and delivery of high-end network processing technology. Geographically, it derives a majority of its revenue from the United States and also has a presence in Asia, Europe, Israel, and the United States. Its product categories include ENET Network Appliances, PON Devices ACE-NIC SmartNICs, ENET Flow Processors, and FPGA Boards.

ETHERNITY NETWORKS LTD by Ethernity Networks Ltd.

Ethernity Networks Ltd

BWS Financial analyst Hamed Khorsand maintains Immersion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMMR#NASDAQ">IMMR</a>) with a Buy and maintains $13.5 price target.

News

Price Target

Analyst Ratings

IMMR

BWS Financial Maintains Buy on Immersion, Maintains $13.5 Price Target

XAIR

Beyond Air Receives Notification From Nasdaq Stating That The Company Has Been Granted An Additional 180-Day Compliance Period, Or Until August 4, 2025 To Regain Compliance With Nasdaq's Minimum Bid Price Rule

Baird analyst Andrew Wittmann maintains Jacobs Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>) with a Outperform and lowers the price target from $154 to $148.

Baird Maintains Outperform on Jacobs Solutions, Lowers Price Target to $148

BWS Financial analyst Hamed Khorsand maintains A10 Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATEN#NYSE">ATEN</a>) with a Buy and maintains $24 price target.

ATEN

BWS Financial Maintains Buy on A10 Networks, Maintains $24 Price Target

WIIM

SMCI

Super Micro Computer shares are trading higher after the company announced the full production of NVIDIA Blackwell rack-scale solutions with NVIDIA HGX B200.

<a href="https://www.sec.gov/Archives/edgar/data/715153/000119312525020499/d878946d6k.htm" title="https://www.sec.gov/Archives/edgar/data/715153/000119312525020499/d878946d6k.htm">https://www.sec.gov/Archives/edgar/data/715153/000119312525020499/d878946d6k.htm</a>

NSANY

Honda Motor Reports On Integration Of Management Between Nissan Motor & Honda Says Nissan & Co Are In Stage Of Advancing Various Discussions

IVVD

Invivyd Announces A Strategic Partnership With Professional Football Coach Jim Harbaugh To Raise Awareness About the Ongoing Short And Potential Long-Term Risks of COVID-19 To The Broad Population

Baird analyst Ghansham Panjabi maintains Graphic Packaging Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPK#NYSE">GPK</a>) with a Outperform and lowers the price target from $36 to $32.

Baird Maintains Outperform on Graphic Packaging Holding, Lowers Price Target to $32

Telsey Advisory Group analyst Dana Telsey maintains Capri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) with a Market Perform and maintains $23 price target.

CPRI

Telsey Advisory Group Maintains Market Perform on Capri Holdings, Maintains $23 Price Target

Canada-based global medical cannabis company&nbsp;Aurora Cannabis Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) reported a third-quarter fiscal 2025 net revenue of CA$88.2 million, compared to&nbsp;CA$64.4 <a target="_blank" href="https://www.benzinga.com/quote/ACB" rel="noreferrer noopener">million a year ago</a>.
The 37% increase from the prior period was mainly due to 51% growth in the global medical cannabis business and 22% in the plant propagation business, slightly offset by lower quarterly revenue in the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43490408/aurora-cannabis-announces-fiscal-2025-third-quarter-results" rel="noreferrer noopener">consumer cannabis business</a>.
Consolidated adjusted gross margin was 65% in the third quarter and 53% in the prior-year quarter. Adjusted gross profit was&nbsp;CA$56.0 million&nbsp;in the third quarter vs.&nbsp;CA$33.6 million&nbsp;in the prior year quarter, an increase of 67%.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/01/43195749/the-week-in-cannabis-trumps-dea-pick-tysons-reform-push-dutch-coffee-shop-crisis-and-more" rel="noreferrer noopener">The Week In Cannabis: Trump&#8217;s DEA Pick, Tyson&#8217;s Reform Push, Dutch Coffee Shop Crisis And More</a>
Medical cannabis net revenue was CA$68.1 million, a 51% increase from the prior-year quarter, driven by CA$23.1 million was primarily due to higher sales to Australia, Germany, Poland and the UK, as well as increased revenue in Canada to insurance covered and self-paying patients.
The adjusted gross margin reached 74%, compared to 63% in the prior year quarter, through sustainable cost reductions, higher selling prices, and improved efficiency in production operations, including sourcing for&nbsp;Europe&nbsp;from&nbsp;Canada.
Aurora&#8217;s consumer cannabis net revenue&nbsp;was&nbsp;CA$9.9 million, a 15% decrease compared to&nbsp;$11.6 million&nbsp;in the prior year quarter, mainly due to the decision to prioritize the supply of GMP manufactured products to high-margin global medical cannabis business rather than the consumer business, which offers lower margins.
Plant propagation net revenue contributed&nbsp;$8.9 million, a 22% increase compared to&nbsp;$7.3 million&nbsp;a year ago, due to organic growth and expanded product offerings arising from increased capacity.
Adjusted EBITDA&nbsp;increased 316% to&nbsp;CA$23.1 million&nbsp;compared to&nbsp;CA$5.5 million&nbsp;a year ago.
&#8220;This quarter was record-breaking for Aurora, driven by all-time highs in global medical net revenue, net income, adjusted EBITDA, and free cash flow,&#8221; said Miguel Martin, executive chairman and CEO for Aurora Cannabis.
Fiscal Q4 2025 Expectations:
<ul>
<li>Revenue is expected to grow, driven by international medical cannabis sales.</li>
<li>Seasonal increase in plant propagation revenue, following usual trends.</li>
<li>Strong profit margins and continued positive adjusted EBITDA.</li>
<li>Lower operating cash use due to disciplined spending and revenue growth.</li>
<li>Free cash flow should be slightly positive as cash use improves.</li>
</ul>
Price Action: ACB stock is up 31.3% at $4.83 during the premarket session at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43491991/novo-nordisk-records-more-than-double-wegovy-sales-in-q4-seeks-regulatory-approval-for-hybrid-weight-loss-drug-in-2026" target="_blank" rel="noreferrer noopener">Novo Nordisk Q4 Earnings: Wegovy Sales More Than Double, Seeks Regulatory Approval For Hybrid Weight Loss Drug In 2026</a></li>
</ul>

Cannabis

Earnings

Guidance

Movers

Trading Ideas

General

Aurora Cannabis Stock Jumps On 'Record-Breaking' Q3 Earnings

BBAI

BigBear.Ai shares are trading higher after the company announced a contract by the DOD's chief digital and artificial intelligence office.

Baird analyst David Leiker maintains Cummins (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) with a Neutral and raises the price target from $395 to $407.

Baird Maintains Neutral on Cummins, Raises Price Target to $407

Beyond Air Granted 180-Day Extension To Regain Nasdaq Compliance

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Baird raised Mercury Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRCY#NASDAQ">MRCY</a>) price target from $37 to $58. Baird analyst Peter Arment upgraded the stock from Neutral to Outperform. Mercury Systems shares closed at $42.09 on Tuesday. <a href="https://www.benzinga.com/quote/MRCY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho raised the price target for Hilton Worldwide Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>) from $243 to $263. Mizuho analyst Ben Chaiken downgraded the stock from Outperform to Neutral. Hilton Worldwide shares closed at $258.74 on Tuesday. <a href="https://www.benzinga.com/quote/HLT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>DA Davidson cut The Clorox Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) price target from $171 to $169. DA Davidson analyst Linda Bolton Weiser maintained a Neutral rating. Clorox shares closed at $148.21 on Tuesday. <a href="https://www.benzinga.com/quote/CLX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham raised the price target for Silicon Laboratories Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) from $140 to $150. Needham analyst Quinn Bolton maintained a Buy rating. Silicon Laboratories shares closed at $136.60 on Tuesday. <a href="https://www.benzinga.com/quote/SLAB/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stephens &amp; Co. cut the price target for Chipotle Mexican Grill, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) from $61 to $60. Stephens &amp; Co. analyst Jim Salera maintained an Equal-Weight rating. Chipotle shares closed at $59.02 on Tuesday. <a href="https://www.benzinga.com/quote/CMG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan raised Janus Henderson Group plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHG#NYSE">JHG</a>) price target from $44 to $53. JP Morgan analyst Kenneth Worthington upgraded the stock from Neutral to Overweight. Janus Henderson shares settled at $44.02 on Tuesday. <a href="https://www.benzinga.com/quote/JHG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup raised Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) price target from $47 to $57. Citigroup analyst Filippo Falorni upgraded the stock from Sell to Neutral. Molson Coors shares closed at $52.95 on Tuesday. <a href="https://www.benzinga.com/quote/TAP/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo cut Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) price target from $15 to $11. Wells Fargo analyst Ken Gawrelski downgraded the stock from Overweight to Equal-Weight. Snap shares closed at $11.60 on Tuesday.  <a href="https://www.benzinga.com/quote/SNAP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc cut the price target for Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) from $150 to $140. Keybanc analyst John Vinh maintained an Overweight rating. AMD shares settled at $119.50 on Tuesday. <a href="https://www.benzinga.com/quote/AMD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Canaccord Genuity raised Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) price target from $650 to $700. Canaccord Genuity analyst Maria Ripps maintained a Buy rating. Spotify shares closed at $621.77 on Tuesday. <a href="https://www.benzinga.com/quote/SPOT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43460681/jim-cramer-says-no-to-bigbear-ai-recommends-buying-this-tech-stock">Jim Cramer Says No To BigBear.ai, Recommends Buying This Tech Stock</a></li>
</ul>

Markets

Janus Henderson Group plc Ordinary Shares

MRCY

SLAB

SNAP

SPOT

Spotify To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Wednesday

Richmond FED President Barkin: Says There Are Jobs Out There That Had Been Devalued That Have Been Revalued Up Because Of Scarcity

Offerings

SXTP

60 Degrees Pharma Announces $1.075M Registered Direct Offering Of 1,503,500 Shares At $0.715/Share

Tech

MSFT

OpenAI Says Deep Research Now Rolled Out To 100% Of Pro Users

Baird analyst Ghansham Panjabi maintains Ball (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BALL#NYSE">BALL</a>) with a Outperform and lowers the price target from $70 to $63.

BALL

Baird Maintains Outperform on Ball, Lowers Price Target to $63

Mexican President Sheinbaum Says Her Government's Goal Is To Use All Mexican Crude Oil For Domestic Refining

Shares of agribusiness and food company Bunge Global SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>) are trading lower in <a href="https://www.benzinga.com/premarket">premarket on Wednesday</a>.
Here&#8217;s a breakdown of the company&#8217;s report: 
<ul>
<li>Fourth-quarter FY24 sales declined 9.33% year-on-year to $13.54 billion, missing the analyst <a href="https://www.benzinga.com/pressreleases/25/02/b43489190/bunge-reports-fourth-quarter-and-full-year-2024-results">consensus estimate of $13.60 billion</a>.</li>
<li>Adjusted EPS of $2.13 <a href="https://www.benzinga.com/earnings">missed the consensu</a>s estimate of $2.24.</li>
<li>Net sales from the Agribusiness segment declined 9.5% to $9.9 billion, and Refined &amp; Specialty Oils decreased 7.4% to $3.3 billion.</li>
<li>Gross profit improved 13.8% Y/Y to $1.08 billion. Adjusted core segment EBIT amounted to $548 million, an 37.7% decrease Y/Y.</li>
<li>Adjusted EBIT plunged 46.8% to $445 million. The operating cash flow for twelve months totaled $1.9 billion.</li>
</ul>
Also Read: <a href="https://www.benzinga.com/25/02/43460249/pepsicos-q4-sales-miss-estimates-on-downcast-performance-in-north-america-stock-dives">PepsiCo Q4 Earnings: EPS Beat, Subdued North America Performance, 5% Dividend Hike And More</a>
Bunge held $3.31 billion in cash and equivalents as of Dec. 31, 2024.
&#8220;While we didn&#8217;t end the year as we expected and our forward visibility is limited by the increased geopolitical uncertainty, we are confident that the work we&#8217;ve done to further strengthen our business will allow us to continue to create value for all stakeholders,&#8221; said CEO Greg Heckman.
Outlook: Bunge sees fiscal 2025 adjusted EPS of approximately $7.75, with an estimate of $8.81.
Bunge expects to incur capital expenditures of $1.5 billion &#8211; $1.7 billion. The company sees FY25 net interest expense in the range of $250 million to $280 million.&nbsp;
In Agribusiness, FY25 results are forecasted to be down from last year due to lower results in Processing where higher results in South America are expected to be more than offset by lower results in North America and European softseeds.
Price Action: Bunge shares are trading lower by 4.71% at $71.49 in premarket at the last check Wednesday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43463646/alcohol-giant-diageo-suspends-guidance-as-trumps-tariff-looms">Alcohol Giant Diageo Suspends Medium-Term Guidance As Trump&#8217;s Tariff Looms</a></li>
</ul>
Image: Shutterstock

Comments

Ethernity Networks

Ethernity Networks (ENETF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga